Pfizer gains after strong Q1 result

Pfizer rose 0.86% to Rs 2,124 at 14:12 IST on BSE after net profit rose 43.4% to Rs 53.83 crore on 10.9% growth in total income to Rs 501.01 crore in Q1 June 2015 over Q1 June 2014.

Meanwhile, the BSE Sensex was down 438.58 points, or 1.56%, to 27,673.73

On BSE, so far 4,875 shares were traded in the counter, compared with an average volume of 2,960 shares in the past one quarter.

The stock hit a high of Rs 2,161.80 and a low of Rs 2,117.10 so far during the day. The stock hit a record high of Rs 2,425 on 8 April 2015. The stock hit a 52-week low of Rs 1,321.05 on 6 August 2014.

The stock had outperformed the market over the past one month till 24 July 2015, rising 4.73% compared with Sensex's 1.38% rise. The scrip, however, underperformed the market in past one quarter, falling 1.91% as against Sensex's 2.46% gain.

The mid-cap company has an equity capital of Rs 45.75 crore. Face value per share is Rs 10.

Pfizer's pharmaceuticals product portfolio spans a wide range of therapeutic classes from vitamins supplements and nutritional to antibiotics and cardiovascular.

Powered by Capital Market - Live News